Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: BSE India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aasda Lifecare Ltd

+ Add to Watchlist

ALIF:IN

7.90 INR 0.000.00%

As of 06:00:44 ET on 03/27/2015.

Snapshot for Aasda Lifecare Ltd (ALIF)

Open: 7.90 Day's Range: 7.90 - 7.90 Volume: 0
Previous Close: 7.90 52wk Range: 5.20 - 10.90 1-Yr Rtn: +27.63%

Stock Chart for ALIF

No chart data available.
  • ALIF:IN 7.90
  • 1D
  • 1M
  • 1Y
7.90
Interactive ALIF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALIF

Current P/E Ratio (ttm) 0.3200
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.0168
Earnings Per Share (ttm) 24.6900
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 83.47
Shares Outstanding (M) 10.57
30 Day Average Volume 1
Price/Book (mrq) 0.0906
Price/Sale (ttm) 0.0261
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 0.1000
Dividend Ex-Date 09/22/2010
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALIF

No data available

Company Profile & Key Executives for ALIF

Aasda Lifecare Ltd. researches and manufactures pharmaceuticals. The Company produces analgesics, animal health products, anti-obesity drugs, anti-malarials, erectile dysfunction treatments, expectorants, hormone replacement therapy, vitamins, and anti-tuberculosis drugs.

Kannan Kashi VishwanathManaging Director/Founder
More Company Profile & Key Executives for ALIF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil